Clovis In Pole Position To Be First PARP For Prostate Cancer

 
• By Kevin Grogan
  
Triton
Rubraca performed well in TRITON2 trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip